Lindab International AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Simply Wall St · 3d ago

The quarterly results for Lindab International AB (publ) (STO:LIAB) were released last week, making it a good time to revisit its performance. The result was positive overall - although revenues of kr3.2b were in line with what the analysts predicted, Lindab International surprised by delivering a statutory profit of kr2.42 per share, modestly greater than expected. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Lindab International after the latest results.

earnings-and-revenue-growth
OM:LIAB Earnings and Revenue Growth October 28th 2026

Taking into account the latest results, the current consensus from Lindab International's three analysts is for revenues of kr13.5b in 2027. This would reflect an okay 6.5% increase on its revenue over the past 12 months. Per-share earnings are expected to shoot up 66% to kr10.20. In the lead-up to this report, the analysts had been modelling revenues of kr13.6b and earnings per share (EPS) of kr10.13 in 2027. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

View our latest analysis for Lindab International

It will come as no surprise then, to learn that the consensus price target is largely unchanged at kr142. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. Currently, the most bullish analyst values Lindab International at kr160 per share, while the most bearish prices it at kr130. Still, with such a tight range of estimates, it suggeststhe analysts have a pretty good idea of what they think the company is worth.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Lindab International's past performance and to peers in the same industry. The period to the end of 2027 brings more of the same, according to the analysts, with revenue forecast to display 5.1% growth on an annualised basis. That is in line with its 4.6% annual growth over the past five years. Compare this with the broader industry (in aggregate), which analyst estimates suggest will see revenues grow 8.2% annually. So it's pretty clear that Lindab International is expected to grow slower than similar companies in the same industry.

The Bottom Line

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target held steady at kr142, with the latest estimates not enough to have an impact on their price targets.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. At Simply Wall St, we have a full range of analyst estimates for Lindab International going out to 2028, and you can see them free on our platform here..

And what about risks? Every company has them, and we've spotted 1 warning sign for Lindab International you should know about.